Nicholas Chang, DPM
Foot & Ankle Surgery · Mount Vernon, WANPI 1265094700
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,639 of the $5,844 with a category attached, or 62.3%. 17 manufacturers reported payments, led by Smith+Nephew at 38.7% of the total. 2025 is the largest year on record at $3,482, more than ten times the $134 reported in 2022.
Across 65 payments — averaging $89.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$2K
- Treace Medical Concepts, Inc.$958
- Arthrex$573
- Stryker$534
- Paragon 28, Inc.$496
- Invictus Surgical Incorporated$419
- plus $604 from 11 others
What the payments were for
- Travel & lodging$3,63962%
- Food & beverage$2,20538%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 17 | $2,261 |
| Treace Medical Concepts, Inc. | 9 | $958 |
| Arthrex | 4 | $573 |
| Stryker | 2 | $534 |
| Paragon 28, Inc. | 4 | $496 |
| Invictus Surgical Incorporated | 4 | $419 |
| Organogenesis Inc. | 4 | $154 |
| Paratek Pharmaceuticals, Inc. | 5 | $93 |
| Fusion Orthopedics USA, LLC | 3 | $78 |
| Bioventus LLC | 2 | $54 |
| Next Science LLC | 3 | $51 |
| Orthofix Medical, Inc. | 2 | $46 |
| Averitas Pharma Inc. | 2 | $38 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $26 |
| KCI USA, Inc. | 1 | $23 |
| Mimedx Group, Inc. | 1 | $23 |
| AbbVie | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PICO$1,931
- Grafix$1,371
- Versajet$1,371
- COLLAGENASE SANTYL$1,371
- Lapiplasty System$668
- PROstep$431
- Portfolio$421
- ORTHOLOC 2 LAPIFUSE$103
How this compares
$5,844 in reported general payments places this provider in the 75th percentile of 203 foot & ankle surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 79 | $568 |
| Pregabalin | 11 | $535 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 41 | $444 |
| Colchicine | 12 | $379 |
| Ketoconazole | 12 | $371 |
| Cephalexin | 29 | $154 |
| Ondansetron OdtOndansetron | 11 | $147 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $120 |
| Methylprednisolone | 15 | $79 |
| Levofloxacin | 12 | $49 |
| Meloxicam | 13 | $23 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Mount Vernon
- Emily ChauMount Vernon$12K
- Jeffrey ChristensenEverett$828K
- David DalstromSeattle$491K
- Richard LamourOlympia$87K
- Adam AlbabaSeattle$46K
- Stephen BenirschkeSeattle$45K
- Craig CliffordFederal Way$44K
- Shawn KhademiRenton$43K
- Gregory GrabowskiBellevue$34K
- Jacob McLeodLongview$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.